Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

LARS Antikörper (AA 250-300)

LARS Reaktivität: Human, Maus WB, IHC (fp) Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN7454577
  • Target Alle LARS Antikörper anzeigen
    LARS (Leucyl-tRNA Synthetase (LARS))
    Bindungsspezifität
    • 4
    • 4
    • 4
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    AA 250-300
    Reaktivität
    • 18
    • 8
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Human, Maus
    Wirt
    • 20
    Kaninchen
    Klonalität
    • 20
    Polyklonal
    Konjugat
    • 17
    • 1
    • 1
    • 1
    Dieser LARS Antikörper ist unkonjugiert
    Applikation
    • 17
    • 6
    • 5
    • 4
    • 3
    • 3
    • 2
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections) (IHC (fp))
    Verwendungszweck
    Rabbit anti-LARS Antibody, Affinity Purified
    Homologie
    Orangutan
    Aufreinigung
    Affinity Purified
    Immunogen
    Between AA 250 and 300
    Isotyp
    IgG
    Top Product
    Discover our top product LARS Primärantikörper
  • Applikationshinweise

    IHC: 1:500 - 1:2,000. Epitope retrieval with citrate buffer pH 6.0 is recommended for FFPE tissue sections.

    IP: Not recommended

    WB: 1:1,000 - 1:5,000

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    1000 μg/mL
    Buffer
    Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09 % Sodium Azide
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C
    Haltbarkeit
    12 months
  • Target
    LARS (Leucyl-tRNA Synthetase (LARS))
    Andere Bezeichnung
    LARS (LARS Produkte)
    Synonyme
    HSPC192 antikoerper, LARS1 antikoerper, LEURS antikoerper, LEUS antikoerper, LRS antikoerper, PIG44 antikoerper, RNTLS antikoerper, hr025Cl antikoerper, CG7479 antikoerper, Dmel\\CG7479 antikoerper, LeuRS antikoerper, F21M12.1 antikoerper, F21M12_1 antikoerper, BA4991 antikoerper, DDBDRAFT_0183834 antikoerper, DDBDRAFT_0231251 antikoerper, DDB_0183834 antikoerper, DDB_0231251 antikoerper, 2310045K21Rik antikoerper, 3110009L02Rik antikoerper, AW536573 antikoerper, mKIAA1352 antikoerper, leucyl-tRNA synthetase antikoerper, Leucyl-tRNA synthetase, mitochondrial antikoerper, ATP binding/leucine-tRNA ligases/aminoacyl-tRNA ligase antikoerper, leucine--tRNA ligase antikoerper, leucyl-tRNA synthetase LeuS antikoerper, leucyl-tRNA ligase antikoerper, leucine-tRNA ligase antikoerper, LARS antikoerper, LeuRS-m antikoerper, AT1G09620 antikoerper, leuS antikoerper, APH_RS02290 antikoerper, mleuS antikoerper, Lars antikoerper
    Hintergrund
    Background: Leucyl-tRNA synthetase (LARS) catalyzes the specific attachment of an amino acid to its cognate tRNA in a two step reaction: the amino acid (AA) is first activated by ATP to form AA-AMP and then transferred to the acceptor end of the tRNA. LARS exhibits a post-transfer editing activity to hydrolyze mischarged tRNAs [taken from the Universal Protein Resource (UniProt) Q9P2J5].
    Gen-ID
    51520
    NCBI Accession
    NP_064502
    UniProt
    Q9P2J5
    Pathways
    EGFR Signaling Pathway
Sie sind hier: